If you suffered substantial losses and wish to serve as lead plaintiff of the Elevance Health class action lawsuit, or just have general questions about you rights as a shareholder, please contact attorney Timothy L. Miles of the Law Offices of Timothy L. Miles, at no cost, by calling 855/846-6529 or via e-mail at [email protected]. Lead plaintiff motions for the Elevance Health class action lawsuit must be filed with the court no later than July 11, 2025.
Read on for answers to six of the most frequently asked questions from investors about the Elevance Health class action lawsuit.
1. What Are the Allegations in the Elevance Health Class Action Lawsuit?
Elevance Health operates as a health benefits company. Among other things, the cost of providing health benefits to members is driven by the level of care a patient requires, often referred to as “acuity,” and the members’ utilization of the health benefits, according to the complaint.

The Elevance Health class action lawsuit alleges that defendants throughout the class period made false and/or misleading statements and/or failed to disclose that:
- Medicaid redeterminations were causing the acuity and utilization of Elevance Health’s Medicaid members to rise significantly, as the members being removed from Medicaid programs were, on average, healthier than those who remained eligible for the programs; and
- This shift was occurring to a degree that was not reflected in Elevance Health’s rate negotiations with the states or in its financial guidance for 2024.
The Elevance Health lawsuit further alleges that on July 17, 2024, Elevance Health revealed that it was now “expecting second half utilization to increase in Medicaid” and that it was “seeing signs of increased utilization across the broader Medicaid population, including in outpatient home health, radiology, durable medical equipment as well as some elective procedures.” On this news, the price of Elevance Health stock fell nearly 6%, according to the complaint.
Then, on October 17, 2024, Elevance Health announced its financial results for the third quarter of 2024, revealing that Elevance Health had missed consensus earnings per share (“EPS”) expectations for the quarter by $1.33, or 13.7%, “due to elevated medical costs in [its] Medicaid business.” Elevance Health further revealed that it was lowering EPS guidance for 2024 from $37.20 to $33.00, or 11.3%, as it expected these Medicaid issues to continue, according to the Elevance Health lawsuit.
The Elevance Health lawsuit alleges that on this news, the price of Elevance Health stock fell nearly 11%.

2. What Is the Lead Plaintiff Process in the Elevance Health Class Action Lawsuit?
Under the Private Securities Litigation Reform Act of 1995 (PSLRA):
- Any investor who purchased and suffered losses in Elevance Health stock may seek appointment as lead plaintiff in the Elevance Health class action lawsuit.
- A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class.
- A lead plaintiff acts on behalf of all other class members in directing the class action lawsuit.
- The lead plaintiff can select a law firm of its choice to litigate the Elevance Health lawsuit.
- An investor’s ability to share in any potential future recovery of the class action lawsuit is not dependent upon serving as lead plaintiff.
3. When Is the Lead Plaintiff Deadline in the Elevance Health Lawsuit?
Lead plaintiff motions for the Elevance Health class action lawsuit must be filed with the court no later than July 11, 2025. When a securities class action is filed:
- The person who files the first complaint is required to publish a notice announcing the filing.
- Anyone who wants to be the lead plaintiff on behalf of the class must thereafter file a motion to be appointed as lead plaintiff(s) no later than 60 days after the notice was published.

4. What Are the Benefits of Serving as a Lead Plaintiff in the Elevance Health Lawsuit?
- Negotiating more competitive attorney fees and reducing litigation costs.
- Managing the litigation by overseeing the progress of the case and reviewing important filings.
- Participating in mediation and settlement discussions.
- Having a voice in decision-making processes regarding the settlement.
- No financial risk, as lead counsel covers all costs and expenses and are paid only if they secure a settlement or judgment recovery for the class
- Potentially enjoying long-term benefits from governance reform resulting from the litigation.
5. What Are the Responsibilities the Lead Plaintiff Will Have in the Elevance Health Lawsuit?
- Selecting, monitoring, and overseeing Lead Counsel.
- Reviewing and commenting on court filings on behalf of the class.
- Discussing litigation strategies with the Lead Counsel.
- Attending depositions (if necessary) and giving a deposition.
- Attending hearings (if necessary).
- Participating in mediation and the trial (if necessary).
- Provide input on any decision concerning the settlement of the securities class action.
6. What Are the Eligibility Criteria for Lead Plaintiff Appointment in the Elevance Health Class Action Lawsuit?
To be eligible for appointment as the lead plaintiff in the Elevance Health class action lawsuit, an investor must meet the following criteria:
- Securities Acquisition: The investor must have purchased or acquired Elevance Health, Inc. (NYSE: ELV) securities between April 18, 2024 and October 16, 2024.
- Financial Losses: The investor must have suffered financial losses as a direct result of the alleged securities fraud perpetrated by Elevance Health and its executives.
- Typicality and Adequacy: The investor’s legal claims must be typical of those asserted on behalf of the class, and they must demonstrate their ability to adequately represent the interests of the entire class through experience, resources, and the absence of conflicts of interest.


